D.C. Mayor Muriel Bowser’s administration is deploying $5 million across seven D.C. startups and three business development groups to boost tech startup growth in the District over the next two years.
It also coincided with the publication of the District’s first report since the pandemic that analyzed the state of its tech scene, a sector that, per the report, employed 51,000 people in 2025 and one that is expected to increase 7.9% by 2028.
“This is where the growth is,” Albert said. “This is the energy we want to capture.”
Cole told me the company’s 9,000-square-foot office at 505 Ninth St. NW in Penn Quarter, which opened in September, staffs about a dozen people now.
In the next 12 months, he expects to double the headcount to boost relationships with federal government customers and policymakers.
“The need for advanced sensing capabilities has never been more critical,” Cole said. “The D.C. region is home to a robust defense and national security ecosystem that recognizes the critical role emerging technologies play in advancing national security missions.”
Average direct asking rents for trophy space in D.C. hit $94 per square foot during the quarter ended Sept. 30…
Rent growth is a “positive indicator” of a strengthening office market where demand for high quality space is tightening supply, he said.
“With the limited amount of new construction coming, there’s been a real opportunity for Class A+ and Class A assets to reinvent themselves through proper renovations, ultimately positioning themselves nicely to capture some of this real growth in tenant demand that we’re seeing,” Hall said.
But the event took on an international flair on Tuesday, with 16 startup founders from South Korea attending. The group, members of a Korean startup cohort founded by McLean angel investment firm WayFounder, all plan to expand to the U.S., and the event serves as a gateway to Washington’s tech ecosystem.
As D.C. Startup & Tech Week enters its second decade, event founder and CEO Rachel Koretsky told me the annual gathering of nearly 10,000 has increasingly become a bridge for international enterprises looking to establish U.S. roots through D.C., with its concentration of federal stakeholders and the presence of global companies.
Jerry Maeng, vice president at GensionBio, told me he is already eyeing a D.C.-area office within two years to sit closer to the Food and Drug Administration as he seeks U.S. clearance for the company’s prostate cancer screening device.